0000899243-22-002452.txt : 20220119 0000899243-22-002452.hdr.sgml : 20220119 20220119173511 ACCESSION NUMBER: 0000899243-22-002452 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220118 FILED AS OF DATE: 20220119 DATE AS OF CHANGE: 20220119 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MARAGANORE JOHN CENTRAL INDEX KEY: 0001180432 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39460 FILM NUMBER: 22539852 MAIL ADDRESS: STREET 1: 75 SIDNEY ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Kymera Therapeutics, Inc. CENTRAL INDEX KEY: 0001815442 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 812992166 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 ARSENAL YARDS BLVD., SUITE 230 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 857-285-5314 MAIL ADDRESS: STREET 1: 200 ARSENAL YARDS BLVD., SUITE 230 CITY: WATERTOWN STATE: MA ZIP: 02472 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-01-18 0 0001815442 Kymera Therapeutics, Inc. KYMR 0001180432 MARAGANORE JOHN C/O KYMERA THERAPEUTICS, INC. 200 ARSENAL YARDS BLVD. SUITE 230 WATERTOWN MA 02472 1 0 0 0 Stock Option (Right to Buy) 39.61 2022-01-18 4 A 0 24000 0.00 A 2032-01-17 Common Stock 24000 24000 D The shares subject to this option shall vest in thirty-six (36) equal monthly installments over three (3) years beginning on January 18, 2022. /s/ Bruce Jacobs, as Attorney-in-Fact 2022-01-19